- Home
- CPBI vs IMMX Comparison
CPBI vs IMMX Comparison
Compare CPBI & IMMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPBI
- IMMX
- Stock Information
- Founded
- CPBI 2023
- IMMX 2014
- Country
- CPBI United States
- IMMX United States
- Employees
- CPBI N/A
- IMMX N/A
- Industry
- CPBI
- IMMX Medicinal Chemicals and Botanical Products
- Sector
- CPBI
- IMMX Health Care
- Exchange
- CPBI Nasdaq
- IMMX Nasdaq
- Market Cap
- CPBI 57.1M
- IMMX 50.1M
- IPO Year
- CPBI N/A
- IMMX 2021
- Fundamental
- Price
- CPBI $14.84
- IMMX $2.15
- Analyst Decision
- CPBI
- IMMX Strong Buy
- Analyst Count
- CPBI 0
- IMMX 1
- Target Price
- CPBI N/A
- IMMX $7.00
- AVG Volume (30 Days)
- CPBI 7.0K
- IMMX 57.8K
- Earning Date
- CPBI 01-01-0001
- IMMX 05-20-2025
- Dividend Yield
- CPBI N/A
- IMMX N/A
- EPS Growth
- CPBI 29.70
- IMMX N/A
- EPS
- CPBI 1.62
- IMMX N/A
- Revenue
- CPBI $18,546,000.00
- IMMX N/A
- Revenue This Year
- CPBI N/A
- IMMX N/A
- Revenue Next Year
- CPBI N/A
- IMMX N/A
- P/E Ratio
- CPBI $9.18
- IMMX N/A
- Revenue Growth
- CPBI 13.73
- IMMX N/A
- 52 Week Low
- CPBI $9.96
- IMMX $1.26
- 52 Week High
- CPBI $15.50
- IMMX $2.71
- Technical
- Relative Strength Index (RSI)
- CPBI 53.40
- IMMX 64.97
- Support Level
- CPBI $14.70
- IMMX $1.92
- Resistance Level
- CPBI $14.77
- IMMX $2.32
- Average True Range (ATR)
- CPBI 0.08
- IMMX 0.16
- MACD
- CPBI 0.03
- IMMX 0.03
- Stochastic Oscillator
- CPBI 70.22
- IMMX 75.35
About CPBI Central Plains Bancshares Inc.
Central Plains Bancshares Inc operates as the bank holding company for Home Federal Savings and Loan Association of Grand Island that provides mortgage, consumer, commercial real estate, and commercial loans, The bank business consists primarily of accepting deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential mortgage loans secured by properties located in our primary market area, as well as commercial real estate loans.
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.